{
    "clinical_study": {
        "@rank": "154671", 
        "arm_group": [
            {
                "arm_group_label": "Deferred stenting", 
                "arm_group_type": "Active Comparator", 
                "description": "During primary PCI in STEMI, once TIMI 3 flow has been achieved with guide-wire, aspiration thrombectomy +/- small balloon, stenting is then deferred for a period of 4-16 hours, and patients wait in CCU with administration of IV glycoprotein 2b3a infusion"
            }, 
            {
                "arm_group_label": "Conventional treatment", 
                "arm_group_type": "Sham Comparator", 
                "description": "Conventional treatment in STEMI, with immediate stenting"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators propose a randomised study of deferred stenting in acute STEMI (for\n      between 4-16 hours), once normal flow has been established (TIMI 3) with guide-wire,\n      aspiration thrombectomy +/- small balloon, to assess whether this strategy might reduce the\n      incidence of no-reflow compared to usual care and to make a preliminary assessment of the\n      effects, if any, on clinical and surrogate outcomes."
        }, 
        "brief_title": "Study of Deferred Versus Immediate Stenting in Acute STEMI Conventional Treatment With Immediate Stenting", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": "ST-Elevation Myocardial Infarction", 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        One of the following\n\n          -  Rescue PCI\n\n          -  Prolonged ischaemic time (> 12hours)\n\n          -  Previous MI\n\n          -  Age > 65\n\n          -  Occluded artery (TIMI 0/1) at initial angiography\n\n          -  Thrombus burden (TIMI grade 2+)\n\n          -  Long plaque/ stent length (> 24 mm)\n\n          -  Severe coronary artery disease (e.g calcified artery)\n\n          -  Small reference vessel diameter (< 2.5 mm)\n\n          -  Persistent ST-elevation (> 50%) following reperfusion\n\n          -  Index of microvascular resistance (IMR) > 40\n\n        Exclusion Criteria:\n\n          -  Absence of normal coronary flow (TIMI 3)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "101", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01851291", 
            "org_study_id": "Defer-practice-PG-11-2-28474"
        }, 
        "intervention": [
            {
                "arm_group_label": "Deferred stenting", 
                "intervention_name": "Deferred stenting", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Conventional treatment", 
                "intervention_name": "Conventional treatment", 
                "intervention_type": "Procedure", 
                "other_name": "Conventional treatment in STEMI, with immediate stenting"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "STEMI", 
            "No-reflow", 
            "Primary percutaneous intervention", 
            "Deferred stenting"
        ], 
        "lastchanged_date": "May 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Clydebank", 
                    "country": "United Kingdom", 
                    "state": "Glasgow", 
                    "zip": "G81 4DY"
                }, 
                "name": "Golden Jubilee National Hospital"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomised Controlled Study to Assess Whether Deferred Stenting in Acute STEMI Patients Might Reduce the Incidence of No-reflow Versus Conventional Treatment With Immediate Stenting", 
        "overall_official": {
            "affiliation": "Golden Jubilee National Hospital", 
            "last_name": "Colin Berry, BSc PhD FRCP FACC", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Immediate group - no reflow during index cath lab procedure. Deferred group - no reflow during 2nd cath lab procedure", 
            "measure": "Incidence of angiographic no-reflow - binary", 
            "safety_issue": "No", 
            "time_frame": "During either 1st or 2nd cath lab procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01851291"
        }, 
        "responsible_party": {
            "investigator_affiliation": "NHS National Waiting Times Centre Board", 
            "investigator_full_name": "Prof. Keith G. Oldroyd", 
            "investigator_title": "Professor Keith Oldroyd", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Extent of late microvascular obstruction (MVO) assessed by cardiac MRI", 
                "safety_issue": "No", 
                "time_frame": "MRI 48 hours post reperfusion"
            }, 
            {
                "measure": "Clinical events (hospitalisation for heart failure, re-infarction, cardiac death)", 
                "safety_issue": "Yes", 
                "time_frame": "6-months"
            }, 
            {
                "measure": "Degree of ST-segment resolution on ECG", 
                "safety_issue": "No", 
                "time_frame": "ECG in cath-lab prior to reperfusion and again 60 mins post-reperfusion"
            }, 
            {
                "measure": "TIMI flow grade, corrected TIMI frame count, myocardial blush grade and intra-procedural thrombotic events", 
                "safety_issue": "No", 
                "time_frame": "During index cath lab procedure in immediate stenting group and during 2nd cath lab procedure in deferred stenting group"
            }, 
            {
                "measure": "Culprit vessel dimensions (QCA) and thrombus burden", 
                "safety_issue": "No", 
                "time_frame": "Initial coronary angiogram (and 2nd angiogram in deferred group)"
            }, 
            {
                "measure": "Change in LV ejection fraction, degree of adverse remodelling (end-systolic and end-diastolic volume index), final infarct size, myocardial salvage", 
                "safety_issue": "No", 
                "time_frame": "cardiac MRI 2 days and 6-months post PCI"
            }, 
            {
                "measure": "Index of microvascular resistance (IMR)", 
                "safety_issue": "No", 
                "time_frame": "Immediately post-stenting in both groups"
            }
        ], 
        "source": "NHS National Waiting Times Centre Board", 
        "sponsors": {
            "collaborator": {
                "agency": "British Heart Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Prof. Keith G. Oldroyd", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}